Online Program

324908
An Ounce of Prevention: Deaths Averted from Implementing Evidence-based Primary Prevention Interventions in the United States in 2010


Wednesday, November 4, 2015 : 12:30 p.m. - 12:50 p.m.

Sabrina Hermosilla, PhD, MIA, MPH, MS, MPHIL, Department of Epidemiology at Mailman School of Public Health, Psychiatric Institute of New York, Columbia University, New York, NY
Stephanie Kujawski, MPH, Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY
Catherine Richards, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA
Peter Muennig, MD, MPH, Department of Health Policy and Management, Columbia University, New York, NY
Sandro Galea, MD, DrPH, School of Public Health, Boston University School of Public Health, Boston, MA
Abdulrahman M El-Sayed, MD, DPhil, Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY
The United States (U.S.) lags in the nationwide adoption of primary prevention interventions. However, the potential population health benefit of various primary prevention interventions remains unclear. Based on a systematic review the literature, we estimated the number of deaths that could have been averted in the U.S. in 2010 if all rigorously-studied, efficacious primary prevention interventions for which population attributable risk could be estimated were implemented nationwide. We calculated the number of preventable deaths from interventions by applying the population attributable risk formula to the Centers for Disease Control and Prevention Underlying Cause of Death database for all causes of death with greater than 1,000 deaths in 2010. We estimated that 186,498 (7.4%) deaths in the United States could have been averted if all rigorously-studied, efficacious primary prevention protocols were implemented nationwide. Two in 3 deaths averted would have been from cardiovascular disease or malignancy. The proportion of preventable deaths varied by cause of death, prevention protocol, and demographic profile. Protocols ranged in efficacy from RR=0.15 (human papillomavirus vaccine, type 16) to RR and OR=0.88 (school-based smoking prevention program and home fall prevention environment/assistive technology interventions). Implementing a smoking prevention protocol was responsible for the highest number of potential deaths averted in 2010 (51,485; 2.1% of all-cause mortality), despite being among the least efficacious protocols identified. Despite the considerable gaps in the current primary prevention science literature, our findings suggest that increased investment in efficacious primary prevention across all sectors could result in substantial improvements in mortality.

Learning Areas:

Administer health education strategies, interventions and programs
Advocacy for health and health education
Epidemiology
Implementation of health education strategies, interventions and programs
Protection of the public in relation to communicable diseases including prevention or control
Public health or related public policy

Learning Objectives:
Describe the main causes of death in the United States in 2010. Assess the impact of primary prevention interventions on the main causes of death in the United States in 2010.

Keyword(s): Prevention, Mortality

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a doctoral student in Epidemiology and have over 14 years experience conducting research projects. I have been the lead analyst on this project for 18 months and have been involved in prevention work for years.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.